Nalaganje...
Vedolizumab in the treatment of Crohn’s disease of the pouch
BACKGROUND: Our recent study showed the efficacy and safety of vedolizumab in the treatment of chronic antibiotic-refractory pouchitis. However, there are no published studies on its efficacy and safety in Crohn’s disease (CD) of the pouch. The aim of this study was to assess the efficacy and safety...
Shranjeno v:
| izdano v: | Gastroenterol Rep (Oxf) |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6101609/ https://ncbi.nlm.nih.gov/pubmed/30151202 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/gastro/goy014 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|